The subcutaneous implantable cardioverter defibrillator: State-of-the-art review

Christopher J. McLeod, Lucas Boersma, Hideo Okamura, Paul Andrew Friedman

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalEuropean Heart Journal
Volume38
Issue number4
DOIs
StatePublished - 2017

Fingerprint

Implantable Defibrillators
Sudden Cardiac Death
Registries
Cohort Studies
Technology
Equipment and Supplies
Therapeutics
Rib Cage

Keywords

  • ICD implant
  • Subcutaneous implantable cardioverter defibrillator
  • Sudden cardiac death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The subcutaneous implantable cardioverter defibrillator : State-of-the-art review. / McLeod, Christopher J.; Boersma, Lucas; Okamura, Hideo; Friedman, Paul Andrew.

In: European Heart Journal, Vol. 38, No. 4, 2017, p. 247-257.

Research output: Contribution to journalReview article

McLeod, Christopher J. ; Boersma, Lucas ; Okamura, Hideo ; Friedman, Paul Andrew. / The subcutaneous implantable cardioverter defibrillator : State-of-the-art review. In: European Heart Journal. 2017 ; Vol. 38, No. 4. pp. 247-257.
@article{b48b2c55a1fd4199904317c75c2082e8,
title = "The subcutaneous implantable cardioverter defibrillator: State-of-the-art review",
abstract = "The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.",
keywords = "ICD implant, Subcutaneous implantable cardioverter defibrillator, Sudden cardiac death",
author = "McLeod, {Christopher J.} and Lucas Boersma and Hideo Okamura and Friedman, {Paul Andrew}",
year = "2017",
doi = "10.1093/eurheartj/ehv507",
language = "English (US)",
volume = "38",
pages = "247--257",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - The subcutaneous implantable cardioverter defibrillator

T2 - State-of-the-art review

AU - McLeod, Christopher J.

AU - Boersma, Lucas

AU - Okamura, Hideo

AU - Friedman, Paul Andrew

PY - 2017

Y1 - 2017

N2 - The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.

AB - The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.

KW - ICD implant

KW - Subcutaneous implantable cardioverter defibrillator

KW - Sudden cardiac death

UR - http://www.scopus.com/inward/record.url?scp=85015666738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015666738&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehv507

DO - 10.1093/eurheartj/ehv507

M3 - Review article

C2 - 28182222

AN - SCOPUS:85015666738

VL - 38

SP - 247

EP - 257

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 4

ER -